Here’s the assumption that gets small and mid-size pharma companies into trouble more often than any other: that real-world evidence
In pharma and MedTech, market research success hinges on answering questions that traditional surveys and clinical trial data simply can’t
Using Claims Data for Market Research in Pharma and MedTech Read Post »
Here’s what most pharma market access teams discover too late: clinical trial data tells you what can happen under perfect
Real-World Treatment Pathway Analysis Using Aggregated Claims Data Read Post »
When pharma market access directors ask me about the biggest gap in their evidence strategy, it’s almost always the same
Diagnosed Prevalence and Patient Data Solutions for Pharma Read Post »
